BioCentury
ARTICLE | Clinical News

ATX-101: Interim Phase IIIb data

December 10, 2012 8:00 AM UTC

Interim data from the open-label, U.S. Phase IIIb Study ATX-101-11-26 trial in 165 patients aged 18 and older with submental fat showed that 2 mg/cm 2 ATX-101 given in 28-day cycles for up to 6 cycles...